Community-acquired Pneumonia with Methicillin-resistant Staphylococcus Aureus in a Patient Admitted to the Intensive Care Unit: A Therapeutic Challenge.

Autor:	Pham J; Department of Internal Medicine, University of Missouri Kansas City (UMKC)., Asif T; Department of Internal Medicine, University of Missouri Kansas City (UMKC)., Hamarshi MS; Department of Critical Care Medicine, Saint Lukes Hospital, University of Missouri Kansas City (UMKC).
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2018 Jan 03; Vol. 10 (1), pp. e2019. Date of Electronic Publication: 2018 Jan 03.
DOI:	10.7759/cureus.2019
Abstrakt:	Methicillin-resistant S taphylococcus aureus (MRSA) was previously considered a purely nosocomial pathogen. However, community-acquired MRSA has recently emerged as an important cause of severe necrotizing community-acquired pneumonia (CA-MRSA) in previously healthy individuals. This new pathogen exhibits antibiotic resistance and is linked to extended hospital stay and higher mortality. CA-MRSA has presented new therapeutic challenges due to high vancomycin treatment failure and lack of specificity of clinical findings. There is emerging evidence that treatment with linezolid leads to better patient outcomes in patients with CA-MRSA. Through this case, we aim to raise awareness about early institution of therapy for CA-MRSA whenever it is suspected, to improve patient outcomes. Competing Interests: The authors have declared that no competing interests exist.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu